Why is Tymlos limited to 2 years?
Abaloparatide
Medications
Status:
Open Apr 17, 2026 - 10:35 AM
1answer
Answer
Apr 17, 2026 - 10:35 AM
Tymlos (abaloparatide) is limited to 2 years of use because long-term use may increase the risk of osteosarcoma, a rare bone cancer, as seen in animal studies. To minimize this potential risk, treatment duration is restricted to a maximum of 2 years over a patient’s lifetime.
View More Product Details
Browse by Category
Medications
View our complete selection of Medications to find the one that suites your needs.
View All
View all Medications Questions & Answers
View all Abaloparatide Questions & Answers